Catalyst Wire Dossier Catalyst Wire Dossier

LUPRON DEPOT-PED

Leuprolide acetate · AbbVie Inc.
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for LUPRON DEPOT-PED, covering 2008-07-31 to 2025-11-14. Get the full timeline:

Most recent: FDA Approved: LUPRON DEPOT-PED — Supplemental Application (AbbVie Inc.)

See pricing